Press Release / Media Release
Zydus receives final approval from the USFDA for Nifedipine Extended-Release Tablets USP21-12-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Nifedipine Extended-Release Tablets USPCadila Healthcare says Zydus got USFDA nod to market two drugs
Received final approval to treat Parkinson's disease and acute uncomplicated urinary tract infectionsPress Release / Media Release
Zydus receives final approval from the USFDA for Pramipexole Dihydrochloride Extended-Release Tablets and Nitrofurantoin Capsules USP (macrocrystals)Press Release / Media Release
Zydus receives final approval from the USFDA for Clozapine Tablets USPPress Release / Media Release
Zydus receives tentative approval from the USFDA for Pregabalin CapsulesICMR launches diagnostic kits to detect livestock diseases
These kits will be manufactured and marketed by Zydus Diagnostics, a division of Cadila Healthcare based in AhmedabadPress Release / Media Release (Revised)
Further to today's press release titled 'New diagnostic kits developed to detect rare and neglected infectious diseases', please find attached a revised press release on the same subject.Press Release / Media Release
New diagnostic kits developed to detect rare and neglected infectious diseasesPress Release / Media Release
Zydus receives final approval from the USFDA for Candesartan Cilexetil and Hydrochlorothiazide TabletsPress Release / Media Release
Zydus receives final approval from the USFDA for Topiramate Extended-Release Capsules